FDA warning savages Indian drugmaker for filthy plant, data falsification

27th February 2018 Uncategorised 0

An Indian drugmaker has stopped halted production of a couple of APIs for the U.S. after FDA inspectors found it was falsifying data at its manufacturing complex near Tamil Nadu, India. That was just the beginning of the problems.

More: FDA warning savages Indian drugmaker for filthy plant, data falsification
Source: fierce